FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116770308> ?p ?o ?g. }

• W2116770308 endingPage "564" @default.
• W2116770308 startingPage "564" @default.
• W2116770308 abstract "<h3>Importance</h3> Histamine-2 receptor antagonists (H₂RAs) and proton pump inhibitors (PPIs) are commonly used to prevent gastrointestinal tract (GI) hemorrhage in critically ill patients. The stronger acid suppression of PPIs may reduce the rate of bleeding but enhance infectious complications, specifically pneumonia and<i>Clostridium difficile</i>infection (CDI). <h3>Objective</h3> To evaluate the occurrence and risk factors for GI hemorrhage, pneumonia, and CDI in critically ill patients. <h3>Design, Setting, and Participants</h3> A pharmacoepidemiological cohort study was conducted of adult patients requiring mechanical ventilation for 24 hours or more and administered either an H₂RA or PPI for 48 hours or more while intubated across 71 hospitals between January 1, 2003, and December 31, 2008. Propensity score–adjusted and propensity-matched multivariate regression models were used to control for confounders. <h3>Main Outcomes and Measures</h3> Primary outcomes were secondary diagnoses of<i>International Classification of Diseases, Ninth Revision </i>(<i>ICD-9</i>)–coded GI hemorrhage, pneumonia, and CDI occurring 48 hours or more after initiating invasive ventilation. <h3>Results</h3> Of 35 312 patients, 13 439 (38.1%) received H₂RAs and 21 873 (61.9%) received PPIs. Gastrointestinal hemorrhage (2.1% vs 5.9%;<i>P</i> < .001), pneumonia (27% vs 38.6%;<i>P</i> < .001), and CDI (2.2% vs 3.8%;<i>P</i> < .001) occurred less frequently in the H₂RA group. After adjusting for propensity score and covariates, odds ratios of GI hemorrhage (2.24; 95% CI, 1.81-2.76), pneumonia (1.2; 95% CI, 1.03-1.41), and CDI (1.29; 95% CI, 1.04-1.64) were greater with PPIs. Similar results were obtained in the propensity-matched models of 8799 patients in each cohort. <h3>Conclusions and Relevance</h3> Proton pump inhibitors are associated with greater risks of GI hemorrhage, pneumonia, and CDI than H₂RAs in mechanically ventilated patients. Numerous other risk factors are apparent. These data warrant confirmation in comparative prospective studies." @default.
• W2116770308 created "2016-06-24" @default.
• W2116770308 creator A5010594367 @default.
• W2116770308 creator A5027368636 @default.
• W2116770308 creator A5040757935 @default.
• W2116770308 date "2014-04-01" @default.
• W2116770308 modified "2023-10-16" @default.
• W2116770308 title "Histamine-2 Receptor Antagonists vs Proton Pump Inhibitors on Gastrointestinal Tract Hemorrhage and Infectious Complications in the Intensive Care Unit" @default.
• W2116770308 cites W1608335267 @default.
• W2116770308 cites W1795785110 @default.
• W2116770308 cites W1936347328 @default.
• W2116770308 cites W1981748372 @default.
• W2116770308 cites W1984152908 @default.
• W2116770308 cites W1988687175 @default.
• W2116770308 cites W1991986205 @default.
• W2116770308 cites W1996553052 @default.
• W2116770308 cites W2005877606 @default.
• W2116770308 cites W2007982564 @default.
• W2116770308 cites W2017720118 @default.
• W2116770308 cites W2036193982 @default.
• W2116770308 cites W2040033828 @default.
• W2116770308 cites W2044145896 @default.
• W2116770308 cites W2060186125 @default.
• W2116770308 cites W2062568470 @default.
• W2116770308 cites W2063010414 @default.
• W2116770308 cites W2067391538 @default.
• W2116770308 cites W2069432084 @default.
• W2116770308 cites W2086771308 @default.
• W2116770308 cites W2089973354 @default.
• W2116770308 cites W2091105678 @default.
• W2116770308 cites W2096988592 @default.
• W2116770308 cites W2105534233 @default.
• W2116770308 cites W2107843102 @default.
• W2116770308 cites W2113443314 @default.
• W2116770308 cites W2116612251 @default.
• W2116770308 cites W2125436157 @default.
• W2116770308 cites W2125756825 @default.
• W2116770308 cites W2137841869 @default.
• W2116770308 cites W2139301698 @default.
• W2116770308 cites W2157072639 @default.
• W2116770308 cites W2160967161 @default.
• W2116770308 cites W2319207481 @default.
• W2116770308 cites W2321823406 @default.
• W2116770308 cites W2442246762 @default.
• W2116770308 cites W2569853813 @default.
• W2116770308 cites W2803743745 @default.
• W2116770308 cites W3023390396 @default.
• W2116770308 cites W3023757607 @default.
• W2116770308 doi "https://doi.org/10.1001/jamainternmed.2013.14673" @default.
• W2116770308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24535015" @default.
• W2116770308 hasPublicationYear "2014" @default.
• W2116770308 type Work @default.
• W2116770308 sameAs 2116770308 @default.
• W2116770308 citedByCount "179" @default.
• W2116770308 countsByYear W21167703082014 @default.
• W2116770308 countsByYear W21167703082015 @default.
• W2116770308 countsByYear W21167703082016 @default.
• W2116770308 countsByYear W21167703082017 @default.
• W2116770308 countsByYear W21167703082018 @default.
• W2116770308 countsByYear W21167703082019 @default.
• W2116770308 countsByYear W21167703082020 @default.
• W2116770308 countsByYear W21167703082021 @default.
• W2116770308 countsByYear W21167703082022 @default.
• W2116770308 countsByYear W21167703082023 @default.
• W2116770308 crossrefType "journal-article" @default.
• W2116770308 hasAuthorship W2116770308A5010594367 @default.
• W2116770308 hasAuthorship W2116770308A5027368636 @default.
• W2116770308 hasAuthorship W2116770308A5040757935 @default.
• W2116770308 hasConcept C126322002 @default.
• W2116770308 hasConcept C167135981 @default.
• W2116770308 hasConcept C177713679 @default.
• W2116770308 hasConcept C17923572 @default.
• W2116770308 hasConcept C2776376669 @default.
• W2116770308 hasConcept C2777080012 @default.
• W2116770308 hasConcept C2777914695 @default.
• W2116770308 hasConcept C2778080469 @default.
• W2116770308 hasConcept C2987404301 @default.
• W2116770308 hasConcept C2994496256 @default.
• W2116770308 hasConcept C501593827 @default.
• W2116770308 hasConcept C71924100 @default.
• W2116770308 hasConcept C86803240 @default.
• W2116770308 hasConcept C89423630 @default.
• W2116770308 hasConcept C90924648 @default.
• W2116770308 hasConceptScore W2116770308C126322002 @default.
• W2116770308 hasConceptScore W2116770308C167135981 @default.
• W2116770308 hasConceptScore W2116770308C177713679 @default.
• W2116770308 hasConceptScore W2116770308C17923572 @default.
• W2116770308 hasConceptScore W2116770308C2776376669 @default.
• W2116770308 hasConceptScore W2116770308C2777080012 @default.
• W2116770308 hasConceptScore W2116770308C2777914695 @default.
• W2116770308 hasConceptScore W2116770308C2778080469 @default.
• W2116770308 hasConceptScore W2116770308C2987404301 @default.
• W2116770308 hasConceptScore W2116770308C2994496256 @default.
• W2116770308 hasConceptScore W2116770308C501593827 @default.
• W2116770308 hasConceptScore W2116770308C71924100 @default.
• W2116770308 hasConceptScore W2116770308C86803240 @default.
• W2116770308 hasConceptScore W2116770308C89423630 @default.
• W2116770308 hasConceptScore W2116770308C90924648 @default.

• next